Up to 88% of patients in the treatment group had at least a 10% weight loss, if not more, compared with 4% for placebo
Limnology and Oceanography 56 : 13301342.CrossRefGoogle Scholar Helbling, E
Based on available data and mechanism of action, retatrutide appears most relevant for: People with significant obesity (BMI 35+) who want maximum weight reduction and haven't achieved their goals on semaglutide or tirzepatide People with type 2 diabetes who need both glycemic control and meaningful weight loss People who have plateaued on existing GLP-1 therapy and are wondering if a more powerful triple agonist would move the needle People focused on metabolic longevity , where reducing adiposity, improving insulin sensitivity, and lowering chronic inflammation are all high-priority goals If you're someone chasing a 5-10 lb cosmetic goal, retatrutide is probably overkill
Some researchers keep a 5mg vial specifically for the first two weeks at 1mg (using just 20 units per dose), then switch to larger vials for the remainder of the protocol
Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinsons disease through inhibition of H3K4me3 demethylation